Iron deficiency during pregnancy leads to increased maternal illness, low birth weight, prematurity, and intrauterine growth restriction. Pregnant women with sickle cell disease (SCD) are also at high risk for similar adverse outcomes. Although SCD is known for iron overload related to transfusion ...
Iron deficiency, with or without anemia, affects almost half of pregnancies worldwide, adversely impacting maternal and fetal outcomes. In North America, the estimated prevalence of iron deficiency during pregnancy is reported to be greater than 50%, and nearly 12% of pregnancies are affected by i...
INTRODUCTION: iron deficiency is a major public health concern. Globally, iron deficiency ranks number 9 and is responsible for about 60% of all anemia cases among preschool children. In Africa iron deficiency is 43-52% while in Kenya, children under 5 y
Treatment of iron deficiency anemia in pregnancy and postpartum Iron deficiency (ID), iron deficiency anemia (IDA) and the resulting reduction in blood reserves are one the most common problems in pregnancy. Both oral i... C Breymann,A Krafft - 《Transfusion Alternatives in Transfusion Medicine...
In general, in women with transfusion-dependent thalassemia, during pregnancy, iron chelation therapy is ceased. We report a splenectomized patient, who was an excellent complier with chelation therapy, who before embarking on a pregnancy showed no evidence of iron overload, with normal cardiac, ...
Background: Severe anemia in pregnancy results in relatively poor maternal and fetal outcome. Maternal effects are preterm labor, preeclampsia, sepsis and postpartum hemorrhage and increase need of blood transfusion. In India, the decisi... TOI Anemia - 《International Journal of Infertility & Fetal...
transfusion regimens. Hence as per the facts mentioned above, COVID-19 had a significant impact on the intravenous iron drugs market. However, as the pandemic has subsided, the studied the market is expected to have a stable growth during the forecast period of the study....
IDA affects women more in their childbearing period, which makes them vulnerable to risk of infections, bleeding, postpartum anemia, blood transfusion, and even adverse birth outcomes. Thus, treatment of IDA in pregnancy is extremely important not only for these mothers but also their infants.In ...
This approach was successful both in sus- taining acceptable hemoglobin levels (albeit below the 12.5 g/ dL level recommended by the World Health Organization for women) but generally avoiding symptoms of anemia and the need for high-frequency and high-volume blood transfusions, but SG still...
Preterm infants do not require iron supplements when given repeated blood transfusions.During lactation the total iron losses of the mother are 1 mg/day, and thus no supplementary iron is needed if the iron metabolism has been in balance during the pregnancy.Serum ferritin concentration decreases ...